EBV-associated nasal-type NK/T-cell lymphoma of the nasal cavity/paranasal sinus in a renal allograft recipient

Nephrology Dialysis Transplantation

Volumn 21, Issue 5, 2006, Pages 1413-1416

  Momose, Akishi ^a   Mizuno, Hiroshi ^a   Kajihara, Satoshi ^a   Saitoh, Hisao ^a   Mikuni, Tsuneyasu ^a   Katsunori, Nagai ^a   Funyu, Tomihisa ^a  

^a Hirosaki Hospital   (Japan)

Author keywords

EBV associated lymphoma; Nasal type NK T cell lymphoma; Post transplantation lymphoproliferative disorder; Renal transplantation

Indexed keywords

CARBOPLATIN; CD3 ANTIGEN; CD5 ANTIGEN; CD68 ANTIGEN; DEXAMETHASONE; ETOPOSIDE; GANCICLOVIR; IFOSFAMIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; VIRUS DNA;

ADULT; ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG DOSE REGIMEN; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FACIAL NERVE PARALYSIS; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MALE; NATURAL KILLER T CELL; NOSE CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIAL EFFUSION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; SEROLOGY; T CELL LYMPHOMA; VIRUS IDENTIFICATION; VIRUS INFECTION;

ADULT; BIOPSY, NEEDLE; EPSTEIN-BARR VIRUS INFECTIONS; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; KILLER CELLS, NATURAL; LIVING DONORS; LYMPHOMA, T-CELL; MAGNETIC RESONANCE IMAGING; MALE; PARANASAL SINUS NEOPLASMS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 33646204700     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfk020     Document Type: Article

References (10)

1. Boubenider S, Hiesse C, Goupy C, Kriaa F, Marchand S, Charpentier B. Incidence and consequences of post-transplantation lymphoproliferative disorders. J Nephrol 1997; 10: 135-145
2. Kwong YL, Chan ACL, Liang RHS. Natural killer cell lymphoma/leukemia: pathology and treatment. Hematol Oncol 1997; 15: 71-79
3. Lanier LL, Chang C, Spits H, Phillips JH. Expression of cytoplasmic CD3ε proteins in activated human adult natural killer (NK) cells and CD3 γ, δ, ε complexes in fetal NK cells. J Immunol 1992; 149: 1876-1880
4. Quintanilla-Martinez L, Franklin JL, Guerrero I et al. Histological and immunophenotypic pro.le of nasal NK/T cell lymphomas from Peru: High prevalence of p53 over-expression. Hum Pathol 1999; 30: 849-855
5. Stadlmann S, Fend F, Moser P Obrist P, Griel R, Dirnhofer S. Epstein-Barr virus-associated extranodal NK/T-cell lymphoma, nasal type of the hypopharynx, in a renal allograft recipient: Case report and review of literature. Hum Pathol 2001; 32: 1264-1268
6. Tsao L, Draoua HY, Mansukhani M, Bhagat G, Alobeid B. EBV-associated, extranodal NK-cell lymphoma, nasal type of the breast, after heart transplantation. Mod Pathol 2004; 17: 125-130
7. Hoshida Y, Li T, Dong Z et al. Lymphoproliferative disorders in renal transplant patients in Japan. Int J Cancer 2001; 91: 869-875
8. Minarovits J, Hu LF, Imai S et al. Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. J Gen Virol 1994; 75: 77-84
9. Shahinian VB, Muirhead N, Jevnikar AM et al. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoproliferative disorder in adult renal allograft recipients. Transplantation 2003; 75: 851-856
10. van Gorp J, Doornewaard H, Verdonck LF. Klopping C, Vos PF, van den Tweel JG. Posttransplant T-cell lymphoma: Report of three cases and a review of the literature. Cancer 1994; 73: 3064-3072